Chemical and Pharmaceutical Bulletin p. 2157 - 2160 (1994)
Update date:2022-07-30
Topics:
Morita
Ohtsubo
Matsubara
Ohtani
Uchida
Kido
Shimizu
The enantiomers of 7-fluoro-1-methyl-3-(methylsulfinyl)-4(1H)-quinolinone [(+)-1, flosequinan], a new drug for the treatment of heart failure, were synthesized from the optically active (R)-α-methylbenzylamine derivatives of quinoline. The key intermediates, (R)-α-methylbenzylamine derivatives, were prepared by diastereomeric separation. The configuration of (+)-1 was assigned on the basis of an X-ray crystallographic analysis of the synthetic precursor (4a). The absolute configuration was found to be (R)-(+)-1 and (S)-(-)-1.
View MoreNanjing distinctions Medical Technology Co., Ltd.(expird)
Contact:+86-15996203785 13914714059
Address:nanjing,jiangsu , China
Shandong LuZhou Amino Acid Co., Ltd
Contact:86-539-2218025
Address:yishui economic and technical development zone zhenxing south road
Contact:21-7631221 15884421033
Address:326 Science and technology,Shanghai,China
Contact:86-571-61063068
Address:LINAN
Shandong Jiulong Hisince Pharmaceutical Co.,Ltd.
Contact:--
Address:Huadian Pioneer Park, Huadian Township, Qihe County, Dezhou City, Shandong, P.R.China
Doi:10.1016/S0020-1693(00)83971-7
(1988)Doi:10.1016/j.chemphyslip.2012.10.004
(2012)Doi:10.1021/om990136+
(1999)Doi:10.1016/S0040-4039(01)88027-8
(1969)Doi:10.1016/j.tet.2009.11.111
(2010)Doi:10.1002/jhet.5570360208
(1999)
